(Q46075901)

19 December 2017

title

Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice (English)

1 reference

19 December 2017

author name string

Victoria B Risbrough

1

1 reference

19 December 2017

Richard L Hauger

2

1 reference

19 December 2017

Mary Ann Pelleymounter

3

1 reference

19 December 2017

Mark A Geyer

4

1 reference

19 December 2017

publication date

4 July 2003

1 reference

19 December 2017

published in

Psychopharmacology

1 reference

19 December 2017

volume

170

1 reference

19 December 2017

issue

2

1 reference

19 December 2017

page(s)

178-187

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1007/s00213-003-1535-6

exact match

0 references

cites work

Opposing roles of the amygdala and dorsolateral periaqueductal gray in fear-potentiated startle

1 reference

12 December 2020

GABA-A and 5-HT1A receptor agonists block expression of fear-potentiated startle in mice

1 reference

12 December 2020

Fear-potentiated startle conditioning to explicit and contextual cues in Gulf War veterans with posttraumatic stress disorder

1 reference

12 December 2020

Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development

1 reference

12 December 2020

Roles of the amygdala and bed nucleus of the stria terminalis in fear and anxiety measured with the acoustic startle reflex. Possible relevance to PTSD.

1 reference

12 December 2020

Fear and anxiety: animal models and human cognitive psychophysiology

1 reference

12 December 2020

Corticotropin-releasing factor receptors couple to multiple G-proteins to activate diverse intracellular signaling pathways in mouse hippocampus: role in neuronal excitability and associative learning.

1 reference

12 December 2020

Physiological evidence of exaggerated startle response in a subgroup of Vietnam veterans with combat-related PTSD.

1 reference

12 December 2020

Differential behavioural effects of chronic infusion of CRH 1 and CRH 2 receptor antisense oligonucleotides into the rat brain

1 reference

12 December 2020

Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors

1 reference

12 December 2020

A role for corticotropin releasing factor and urocortin in behavioral responses to stressors.

1 reference

12 December 2020

Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone

1 reference

12 December 2020

Corticotropin-releasing factor: long-lasting facilitation of the acoustic startle reflex

1 reference

12 December 2020

Do centrally administered neuropeptides access cognate receptors?: an analysis in the central corticotropin-releasing factor system.

1 reference

12 December 2020

Corticotropin-releasing hormone and animal models of anxiety: gene-environment interactions

1 reference

12 December 2020

Corticotropin-releasing hormone receptor (type I) antisense targeting reduces anxiety

1 reference

12 December 2020

Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse

1 reference

12 December 2020

The neuroanatomical and neurochemical basis of conditioned fear.

1 reference

12 December 2020

Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain.

1 reference

12 December 2020

A non peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity

1 reference

12 December 2020

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin

1 reference

12 December 2020

Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression

1 reference

12 December 2020

Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2

1 reference

12 December 2020

Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates

1 reference

12 December 2020

The anxiolytic effect of the CRH(1) receptor antagonist R121919 depends on innate emotionality in rats.

1 reference

12 December 2020

Animal models of CRH excess and CRH receptor deficiency display altered adaptations to stress

1 reference

12 December 2020

Reduction of stress-induced behavior by antagonism of corticotropin-releasing hormone 2 (CRH2) receptors in lateral septum or CRH1 receptors in amygdala.

1 reference

12 December 2020

Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2.

1 reference

12 December 2020

Attenuation of fear conditioning by antisense inhibition of brain corticotropin releasing factor-2 receptor.

1 reference

12 December 2020

125I-Antisauvagine-30: a novel and specific high-affinity radioligand for the characterization of corticotropin-releasing factor type 2 receptors

1 reference

12 December 2020

Startle reactivity and anxiety disorders: aversive conditioning, context, and neurobiology

1 reference

12 December 2020

Are different parts of the extended amygdala involved in fear versus anxiety?

1 reference

12 December 2020

Blockade of potentiated startle responding in rats by 5-hydroxytryptamine1A receptor ligands

1 reference

12 December 2020

Role of corticotropin-releasing factor (CRF) receptors in the anorexic syndrome induced by CRF

1 reference

12 December 2020

Posttraining lesions of the amygdala interfere with fear-potentiated startle to both visual and auditory conditioned stimuli in C57BL/6J mice.

1 reference

12 December 2020

The corticotropin-releasing factor1 receptor antagonist R121919 attenuates the behavioral and endocrine responses to stress

1 reference

12 December 2020

Human urocortin II: mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide

1 reference

12 December 2020

Corticotropin-releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide.

1 reference

12 December 2020

Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior.

1 reference

12 December 2020

CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.

1 reference

12 December 2020

Antagonism of CRF(2) receptors produces anxiolytic behavior in animal models of anxiety.

1 reference

12 December 2020

The CRF peptide family and their receptors: yet more partners discovered

1 reference

12 December 2020

Appetite-suppressing effects of urocortin, a CRF-related neuropeptide.

1 reference

12 December 2020

The behavioural effects of corticotropin-releasing factor-related peptides in rats

1 reference

12 December 2020

Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress.

1 reference

12 December 2020

Quantifying fear potentiated startle using absolute versus proportional increase scoring methods: implications for the neurocircuitry of fear and anxiety

1 reference

12 December 2020

Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli.

1 reference

12 December 2020

Brain penetrance, receptor occupancy and antistress in vivo efficacy of a small molecule corticotropin releasing factor type I receptor selective antagonist

1 reference

12 December 2020

Pharmacological evidence supporting a role for central corticotropin-releasing factor(2) receptors in behavioral, but not endocrine, response to environmental stress

1 reference

12 December 2020

Potentiation of acoustic startle by corticotropin-releasing factor (CRF) and by fear are both reversed by alpha-helical CRF (9-41).

1 reference

12 December 2020

Mouse strain differences in the behavioral effects of corticotropin-releasing factor (CRF) and the CRF antagonist alpha-helical CRF9-41.

1 reference

12 December 2020

New directions in the development of antidepressants: the interface of neurobiology and psychiatry

1 reference

12 December 2020

Role of the amygdala and periaqueductal gray in anxiety and panic

1 reference

12 December 2020

Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30

1 reference

12 December 2020

Fear-potentiated startle: a neural and pharmacological analysis

1 reference

12 December 2020

Pharmacological and chemical properties of astressin, antisauvagine-30 and alpha-helCRF: significance for behavioral experiments.

1 reference

12 December 2020

Effects of experimental context and explicit threat cues on acoustic startle in Vietnam veterans with posttraumatic stress disorder

1 reference

12 December 2020

10.1007/S00213-003-1535-6

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017